Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial

BACKGROUND: The 2022 Global Initiative for Asthma guidelines emphasise the inhaled long-acting β(2)-agonist formoterol as part of the first treatment step, and therefore formoterol use among athletes will probably increase. However, prolonged supratherapeutic use of inhaled β(2)-agonists impairs tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jessen, Søren, Lemminger, Anders, Backer, Vibeke, Fischer, Mads, Di Credico, Andrea, Breenfeldt Andersen, Andreas, Bangsbo, Jens, Hostrup, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123513/
https://www.ncbi.nlm.nih.gov/pubmed/37101738
http://dx.doi.org/10.1183/23120541.00643-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123513/
https://www.ncbi.nlm.nih.gov/pubmed/37101738
http://dx.doi.org/10.1183/23120541.00643-2022

Ejemplares similares